Celon Pharma SA banner
C

Celon Pharma SA
WSE:CLN

Watchlist Manager
Celon Pharma SA
WSE:CLN
Watchlist
Price: 22.2 PLN -0.89% Market Closed
Market Cap: zł1.2B

Intrinsic Value

The intrinsic value for Celon Pharma SA (CLN) under the Base Case is hidden PLN. Compared with the current market price of 22.2 PLN, the stock appears hidden .

Intrinsic value calculated using Multiples
Locked

Do our valuations actually work? See backtest results .

CLN Intrinsic Value
LOCKED
Unlock
Today vs. history

CLN looks overvalued.
But is it expensive by its own standards?

See how today’s valuation compares with CLN’s past valuations and how the stock performed after similar periods.

See what happened next Free account required
Monitor CLN
Get notified when the price drops
Track Buy Zone
20% below Intrinsic Value
Get notified when the price drops into your buy zone
Current Price zł22.2
Intrinsic Value Locked
Margin of Safety 20% Locked
Or choose another margin of safety
0% below Intrinsic Value
10% below Intrinsic Value
30% below Intrinsic Value
40% below Intrinsic Value
50% below Intrinsic Value
Custom
Ask AI Assistant
What other research platforms think about CLN?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is CLN valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Celon Pharma SA.

Explain Valuation
Alternatives to CLN

Wall St Price Targets

Capital Returns

Buyback Yield
LOCKED
Debt Paydown Yield
LOCKED

Competitive Landscape

What is the Intrinsic Value of one CLN stock?

The intrinsic value for Celon Pharma SA (CLN) under the Base Case is hidden PLN.

Is CLN stock undervalued or overvalued?

Compared with the current market price of 22.2 PLN, the stock appears hidden.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett